Partial lipodystrophy and chronic hypocomplementemic glomerulonephritis.
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D003165:Complement System Proteins; D003404:Creatinine / Q000097:blood; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D006084:Graft Rejection; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications* / Q000188:drug therapy; D016030:Kidney Transplantation; D008060:Lipodystrophy / Q000150:complications*; D011183:Postoperative Complications; D011507:Proteinuria; D006435:Renal Dialysis; D014184:Transplantation, Homologous
D003907:Dexamethasone; D003165:Complement System Proteins; D003404:Creatinine; D001379:Azathioprine